ARCHIVES

Iressa Authorization In Europe Clarifies Differences Between U.S., E.U. Standards

This article is from The Cancer Letter archive.

Vol. 35 No. 30 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

Genitope Therapy In Phase III Trials For Low-Grade B-Cell Non-Hodgkin’s.

October 26, 2001

Women’s Health Was ‘Highest Priority’ Of House Committee

July 31, 1992

NLST Suggests 18.5 Percent Of LDCT-Detected Cancers Could Be Indolent

December 27, 2013

FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.

March 31, 2000

Tobacco Money Placed In Non-Profit Run By Henschke, Weill Cornell Officials.

March 28, 2008

DRCCA’s New Board Of Scientific Counselors to Meet Sept. 18-19

August 22, 1980